Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Investment Summary

Market Valuation
Undervalued
Consensus
Skip
Best For

How This Company Makes Money

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Business Quality Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

MaxDividends Quality Score

Dividend Score

Sales Growth ORGO

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin ORGO

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income ORGO

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM ORGO

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio ORGO

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Organogenesis Holdings Inc ORGO

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself ORGO

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE 12.67
Enterprise Value Revenue 0.82
Price Sales TTM 0.60
Enterprise Value EBITDA 10.50
Price Book MRQ 1.25

Bottom Line

Organogenesis Holdings Inc

ORGO
Current price
1.86 USD -0.55 USD (-22.82%)
Last closed 2.37 USD
ISIN US68621F1021
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 310 105 664 USD
Yield for 12 month -59.70 %
1Y
3Y
5Y
10Y
15Y
ORGO
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+563 030 000 USD

Last Year

+482 043 000 USD

Current Quarter

+37 228 000 USD

Last Quarter

+225 071 000 USD

Current Year

+425 508 000 USD

Last Year

+366 302 000 USD

Current Quarter

-913 999 USD

Last Quarter

+175 153 000 USD
EBITDA 36 004 000 USD
Operating Margin TTM -174.69 %
Price to Earnings
Return On Assets TTM 2.12 %
PEG Ratio
Return On Equity TTM 0.73 %
Wall Street Target Price 3.00 USD
Revenue TTM 514 704 000 USD
Book Value 1.90 USD
Revenue Per Share TTM 4.05 USD
Dividend Share
Quarterly Revenue Growth YOY -57.10 %
Dividend Yield
Gross Profit TTM 380 313 984 USD
Earnings Per Share -0.12 USD
Diluted EPS TTM -0.12 USD
Most Recent Quarter I 2026
Quarterly Earnings Growth YOY 555.20 %
Profit Margin 0.53 %
Price to Free Cash Flow TTM 6.17

Technical Indicators ORGO

For 52 Weeks

1.54 USD 7.08 USD
50 Day MA 2.45 USD
Shares Short Prior Month 13 803 202
200 Day MA 3.43 USD
Short Ratio 15.78
Shares Short 13 129 255
Short Percent 16.05 %